Hyperlipidemic acute pancreatitis
Conditions
Interventions
Normal group:None
Experimental group:Qingyi Jiangzhi Decoction
Control group:Conventional therapy
Sponsors
The First People’s Hospital of Lianyungang
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age from 18 to 80; 2.Cases that met chinese guidelines of acute pancreatitis; 3.Cases with hypertriglyceridemia; 4.Cases without acute pancreatitis caused by other reasons; 5.Cases with good compliance, patients or family members who understand the study protocol and are willing to participate in the study and maintain their current lifestyle during the study period, and provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Cases with acute pancreatitis caused by other reasons; 2.Chronic pancreatitis or pancreatic cancer patients; 3.Patients with severe organic diseases; 4.Patients who have not used lipid-lowering drugs in the past; 5.Pregnant or lactating women; 6.Patients who have not signed an informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to symptom resolution;Length of stay;Proteomic; | — |
Countries
China
Contacts
Public ContactZiheng Xu
The First People’s Hospital of Lianyungang
Outcome results
None listed